2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Type 1 AIP: new trials by email Literature Review of Type 1 AIP trials Research Report on Type 1 AIP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis Inebilizumab - Type 1 AIP | Phase 4 | Recruiting | Ruijin Hospital | 50 | 2025-10-01 | 2026-10-07 |
| A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence Glucocorticoids, Glucocorticoids+MMF - Type 1 AIP | Phase 4 | Recruiting | Ruijin Hospital | 86 | 2024-06-30 | 2026-10-06 |
Autoimmune Pancreatitis (2) · Recurrence (1)
Autoimmune Diseases (2) · Chronic Disease (2) · Digestive System Diseases (2) · Disease Attributes (2) · Immune System Diseases (2) · Pancreatic Diseases (2) · Pancreatitis (2) · Pancreatitis, Chronic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Glucocorticoids (1) · Prednisone (1) · inebilizumab (1)
Ruijin Hospital (2)
China (2)